OptimizeRx Corporation OPRX 深 沪
等待开盘 05-18 09:30:00 美东时间
5.21
+0.030
+0.58%
华盛通- 最 高5.34
- 今 开5.09
- 成交量 57.28万股
- 最 低 5.09
- 昨 收 5.18
- 总市值 9776.60万
- 52周最高 22.25
- 市盈率 静 19.29
- 换手率 3.05%
- 52周最低 4.57
- 委 比 -97.41%
- 总股本 1876.51万
- 历史最高 99.178
- 量 比 0.62
- 振 幅 4.83%
- 历史最低 3.78
- 每 手 1
- 风险率 4.34%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 潜在涨幅257.14%！瑞杰金融上调InflaRx目标价至9美元，评级升至"强烈买入"
今日重点评级关注：瑞杰金融：上调InflaRx评级至"强烈买入"，目标价从7美元升至9美元；巴克莱：维持Orchestra BioMed Hldgs"超配"评级，目标价从12美元升至13美元
05-14 14:32
Stifel Maintains Buy on OptimizeRx, Lowers Price Target to $14
Stifel analyst David Grossman maintains OptimizeRx (NASDAQ:OPRX) with a Buy and lowers the price target from $17 to $14.
05-13 21:45
美股异动丨OptimizeRx盘前跌4% Q1营收降10%但盈利翻倍 下调全年指引
格隆汇5月13日｜专注于医疗健康领域的数字技术公司OptimizeRx(OPRX.US)盘前跌4%报6美元。消息上，OptimizeRx于5月12日盘后公布了...
05-13 17:16
OptimizeRx Reports Q1 2026 Results: Full Earnings Call Transcript
OptimizeRx (NASDAQ:OPRX) released first-quarter financial results and hosted an...
05-13 05:08
OptimizeRx Secures New Credit Facility to Boost Flexibility
OptimizeRx ( ($OPRX) ) just unveiled an announcement. On May 7, 2026, OptimizeR...
05-13 05:01
OptimizeRx Lowers FY2026 Sales Guidance from $109.000M-$114.000M to $95.000M-$100.000M vs $111.438M Est
OptimizeRx (NASDAQ:OPRX) lowers FY2026 sales outlook from $109.000 million-$114.000 million to $95.000 million-$100.000 million vs $111.438 million estimate.
05-13 04:12
OptimizeRx Q1 Adj. EPS $0.14 Beats $0.00 Estimate, Sales $19.844M Beat $18.353M Estimate
OptimizeRx (NASDAQ:OPRX) reported quarterly earnings of $0.14 per share which beat the analyst consensus estimate of $0.00 by Infinity percent. This is a 75 percent increase over earnings of $0.08 per share from the same
05-13 04:12
Earnings Scheduled For May 12, 2026
Companies Reporting Before The Bell • Sionna Therapeutics (NASDAQ:SION) is proj...
05-12 19:11
OptimizeRx Launches New Programmatic Connection Point Between OptimizeRx's Proprietary EHR Network And DSPs
OptimizeRx Corp. (the "Company") (NASDAQ:OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare providers (HCPs) and patients at the most important
05-11 19:35
